Inhibition of ERK activation has been shown to hinder the transition of hematopoietic progenitor cells, and the absence of ERK1 and ERK2 in murine hematopoietic cells leads to bone marrow aplasia, leukopenia, anemia, and early lethality60,61. This evidence concerns the gene MAPK3 and anemia (phenotype).